Gynecology News and Research

RSS

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor may increase the incidence of autism-spectrum disorders, psychiatric pathology, cognitive problems and poor school performance in their children, according to a new study published in the December 2009 issue of the American Journal of Obstetrics & Gynecology.

2 Dec 2009

MRI can identify placenta accreta in pregnant women, reveals study

A study presented today at the annual meeting of the Radiological Society of North America (RSNA) revealed that MRI is a highly accurate means of identifying placenta accreta, a potentially life-threatening and increasingly common condition that is the leading cause of death for women just before and after giving birth.

1 Dec 2009

Study reveals that ghrelin can increase resistance to Parkinson's disease

Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience.

25 Nov 2009

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Researchers have found that hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer. This protein, alpha-fetoprotein (AFP), may serve as a viable, well-tolerated agent for the treatment and prevention of breast cancer, according to findings published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

25 Nov 2009

Press Ganey releases 'Patient Perspectives on American Health Care' report

Press Ganey Associates, Inc. released today the 2009 Hospital Pulse Report: Patient Perspectives on American Health Care. The report examines patient satisfaction across the country; trends in overall patient perceptions; and variations based on metropolitan areas, services provided within the hospital, hospital size, and patient age.

24 Nov 2009

Study finds depressed or burned out surgeons more likely to commit major error on the job

Surgeons who are burned out or depressed are more likely to say they had recently committed a major error on the job, according to the largest study to date on physician burnout. The new findings suggest that the mental well-being of the surgeon is associated with a higher rate of self-reported medical errors, something that may undermine patient safety more than the fatigue that is often blamed for many of the medical mistakes.

23 Nov 2009

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Laparoscopic surgeons received their first glimpse of Cook Medical’s uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).

23 Nov 2009

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

The addition of a "genetic sonogram" maximizes the accuracy of non-invasive testing for Down syndrome, said a Baylor College of Medicine researcher who was lead author of a landmark study in the current issue of Obstetrics and Gynecology.

21 Nov 2009

Obese patients no more likely to have post-operative complications after robot-assisted laparoscopic myomectomy

Obese patients are no more likely to have post-operative complications than those of average weight when undergoing robotic surgery to remove uterine fibroids, according to a study at Henry Ford Hospital.

20 Nov 2009

mdBriefCase to provide online education course on H1N1 virus in pregnant women

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC) and the Society of Obstetrics and Gynecology of Canada (SOGC), is pleased to provide a new online education course on the H1N1 virus in pregnant women.

18 Nov 2009

Smith & Nephew launches new operative hysteroscopy device

Smith & Nephew's Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States.

17 Nov 2009

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

For the second consecutive year, Colorado received a “D” on the Premature Birth Report Card issued by the March of Dimes. However, the state did show improvement in two key areas that affect prematurity, including the rate of smoking for childbearing-age women.

17 Nov 2009

Antidepressant drug is effective in treating women with low libido

The drug flibanserin, which was originally created as an antidepressant, is effective in treating women with low libido, pooled results from three separate clinical trials have found.

17 Nov 2009

FDA approves Lysteda for treating menorrhagia

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.

16 Nov 2009

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

In the last 10 years, the St. Louis area has seen an alarming increase in new diagnoses of HIV and sexually transmitted infections among 13-24 year-olds. Between 1997-2007, more than 50 new diagnoses of HIV were made each year among adolescents and young adults, who are often disconnected from the health-care system or support services. Nationwide, St. Louis has among the highest rates of sexually transmitted diseases in this age group.

16 Nov 2009

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.

16 Nov 2009

Breast cancer patients who undergo fertility preservation need not delay treatment

A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

13 Nov 2009

New minimally invasive laser treatment saves the lives of twins with TTTS

As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.

13 Nov 2009

Data supports the use of ExAblate as a safe, effective and durable treatment for uterine fibroids

InSightec Ltd. today announced that three new papers published in the November issue of Ultrasound in Obstetrics and Gynecology add to the growing body of data supporting the use of ExAblate(R) as a safe, effective and durable treatment for uterine fibroids.

12 Nov 2009

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.

11 Nov 2009

Gynecology News and Research

Beta 2 adrenergic agonist drugs can increase risk of autism-spectrum disorders in developing fetus

MRI can identify placenta accreta in pregnant women, reveals study

Study reveals that ghrelin can increase resistance to Parkinson's disease

Alpha-fetoprotein, a well-tolerated agent for treatment and prevention of breast cancer

Press Ganey releases 'Patient Perspectives on American Health Care' report

Study finds depressed or burned out surgeons more likely to commit major error on the job

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Genetic sonogram improves accuracy of noninvasive prenatal screening and detection of Down syndrome

Obese patients no more likely to have post-operative complications after robot-assisted laparoscopic myomectomy

mdBriefCase to provide online education course on H1N1 virus in pregnant women

Smith & Nephew launches new operative hysteroscopy device

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

Antidepressant drug is effective in treating women with low libido

FDA approves Lysteda for treating menorrhagia

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

Breast cancer patients who undergo fertility preservation need not delay treatment

New minimally invasive laser treatment saves the lives of twins with TTTS

Data supports the use of ExAblate as a safe, effective and durable treatment for uterine fibroids

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News